-The Hindu The Chinese government is also likely to considering locations in Gujarat, Maharashtra and Tamil Nadu for industrial parks Beijing: Haryana has made available thousands of acres of land for purchase by Chinese companies, State government officials told potential investors here on Wednesday, in an effort to court investment into newly planned industrial bases. Haryana officials told The Hindu that the China Development Bank (CDB) - the powerful State-run bank that is...

-The Hindu There has been a systemic breakdown in the justice delivery system The critics of the Aarushi murder case seem unable to see the wood for the trees. The focus of endless debate on the case has been on an inadequate appreciation of evidence and the role of the media in cases of this nature. The main issue appears to have been missed - the fact that the overcooked scrutiny is...

-Live Mint The survivors are demanding that the 1989 verdict, in which India agreed to a $470 million settlement, be reopened New Delhi: On the intervening night of December 2-3 1984, a highly unstable chemical, methyl isocyanate (MiC), an intermediary substance used to manufacture Sevin, a pesticide, leaked from tank 610 in the Union Carbide plant in Bhopal. The leak was first detected by workers about 11.30pm as their eyes began to...

-Outlook New Delhi: Women activists and senior journalists today expressed dissatisfaction over the way Tehelka management handled the issue of the alleged sexual assault of a woman journalist by its Editor Tarun Tejpal and said law should take its course as it was not an internal matter. They were critical of the statements made by Tehelka Managing Editor Shoma Chaudhury who said it was not a police case which the organisation will...

-Live Mint Apex court expresses concerns about drug trials being permitted on humans without comprehensive rules to regulate the approval process New Delhi: The apex court on Monday directed the health ministry to justify its approval for 162 global clinical trials in India, increasing the uncertainty faced by the nation's $500 million clinical research industry. The Supreme Court expressed its concerns about drug trials being permitted on humans without comprehensive rules to...